Background/Aims: Recently, loss-of-function mutations in the MKRN3 gene have been implicated in the etiology of familial central precocious puberty (CPP) in both sexes. We aimed to analyze the frequency of MKRN3 mutations in boys with CPP and to compare the clinical and hormonal features of boys with and without MKRN3 mutations. Methods: This was a retrospective review of clinical, hormonal and genetic features of 20 male patients with idiopathic CPP evaluated at an academic medical center. The entire coding regions of MKRN3, KISS1 and KISS1R genes were sequenced. Results: We studied 20 boys from 17 families with CPP. All of them had normal brain magnetic resonance imaging. Eight boys from 5 families harbored four distinct heterozygous MKRN3 mutations predicted to be deleterious for protein function, p.Ala162Glyfs*14, p.Arg213Glyfs*73, p.Arg328Cys and p.Arg365Ser. One boy carried a previously described KISS1-activating mutation (p.Pro74Ser). The frequency of MKRN3 mutations among these boys with idiopathic CPP was significantly higher than previously reported female data (40 vs. 6.4%, respectively, p < 0.001). Boys with MKRN3 mutations had typical clinical and hormonal features of CPP. Notably, they had later pubertal onset than boys without MKRN3 abnormalities (median age 8.2 vs. 7.0 years, respectively, p = 0.033). Conclusion: We demonstrated a high frequency of MKRN3 mutations in boys with CPP, previously classified as idiopathic, suggesting the importance of genetic analysis in this group. The boys with CPP due to MKRN3 mutations had classical features of CPP, but with puberty initiation at a borderline age.

Keywords:
Genetics, Gonadotropin-releasing hormone, MKRN3 gene, Male precocious puberty
1.
Carel JC, Leger J: Clinical practice. Precocious puberty. N Engl J Med 2008;358:2366-2377.
2.
Ojeda SR, Lomniczi A: Puberty in 2013: unravelling the mystery of puberty. Nat Rev Endocrinol 2014;10:67-69.
3.
Ojeda SR, Lomniczi A, Mastronardi C, Heger S, Roth C, Parent AS, Matagne V, Mungenast AE: Minireview: the neuroendocrine regulation of puberty: is the time ripe for a systems biology approach? Endocrinology 2006;147:1166-1174.
4.
Susman EJ, Houts RM, Steinberg L, Belsky J, Cauffman E, Dehart G, Friedman SL, Roisman GI, Halpern-Felsher BL: Longitudinal development of secondary sexual characteristics in girls and boys between ages 91/2 and 151/2 years. Arch Pediatr Adolesc Med 2010;164:166-173.
5.
Herman-Giddens ME, Steffes J, Harris D, Slora E, Hussey M, Dowshen SA, Wasserman R, Serwint JR, Smitherman L, Reiter EO: Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network. Pediatrics 2012;130:e1058-e1068.
6.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
7.
Brunner HG, Otten BJ: Precocious puberty in boys. N Engl J Med 1999;341:1763-1765.
8.
Macedo DB, Cukier P, Mendonca BB, Latronico AC, Brito VN: Advances in the etiology, diagnosis and treatment of central precocious puberty (in Portuguese). Arq Bras Endocrinol Metabol 2014;58:108-117.
9.
Choi KH, Chung SJ, Kang MJ, Yoon JY, Lee JE, Lee YA, Shin CH, Yang SW: Boys with precocious or early puberty: incidence of pathological brain magnetic resonance imaging findings and factors related to newly developed brain lesions. Ann Pediatr Endocrinol Metab 2013;18:183-190.
10.
Pigneur B, Trivin C, Brauner R: Idiopathic central precocious puberty in 28 boys. Med Sci Monit 2008;14:CR10-CR14.
11.
Bridges NA, Christopher JA, Hindmarsh PC, Brook CG: Sexual precocity: sex incidence and aetiology. Arch Dis Child 1994;70:116-118.
12.
De Sanctis V, Corrias A, Rizzo V, Bertelloni S, Urso L, Galluzzi F, Pasquino AM, Pozzan G, Guarneri MP, Cisternino M, De Luca F, Gargantini L, Pilotta A, Sposito M, Tonini G: Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000;13(suppl 1):687-693.
13.
Alikasifoglu A, Vuralli D, Gonc EN, Ozon A, Kandemir N: Changing etiological trends in male precocious puberty: evaluation of 100 cases with central precocious puberty over the last decade. Horm Res Paediatr 2015;83:340-344.
14.
Palmert MR, Boepple PA: Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab 2001;86:2364-2368.
15.
Lee HS, Park HK, Ko JH, Kim YJ, Hwang JS: Impact of body mass index on luteinizing hormone secretion in gonadotropin-releasing hormone stimulation tests of boys experiencing precocious puberty. Neuroendocrinology 2013;97:225-231.
16.
de Vries L, Kauschansky A, Shohat M, Phillip M: Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab 2004;89:1794-1800.
17.
Abreu AP, Dauber A, Macedo DB, Noel SD, et al: Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 2013;368:2467-2475.
18.
Bulcao Macedo D, Nahime Brito V, Latronico AC: New causes of central precocious puberty: the role of genetic factors. Neuroendocrinology 2014;100:1-8.
19.
Abreu AP, Macedo DB, Brito VN, Kaiser UB, Latronico AC: A new pathway in the control of the initiation of puberty: the MKRN3 gene. J Mol Endocrinol 2015;54:R131-R139.
20.
Silveira LG, Noel SD, Silveira-Neto AP, Abreu AP, Brito VN, Santos MG, Bianco SD, Kuohung W, Xu S, Gryngarten M, Escobar ME, Arnhold IJ, Mendonca BB, Kaiser UB, Latronico AC: Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab 2010;95:2276-2280.
21.
Schreiner F, Gohlke B, Hamm M, Korsch E, Woelfle J: MKRN3 mutations in familial central precocious puberty. Horm Res Paediatr 2014;82:122-126.
22.
de Vries L, Gat-Yablonski G, Dror N, Singer A, Phillip M: A novel MKRN3 missense mutation causing familial precocious puberty. Hum Reprod 2014;29:2838-2843.
23.
Settas N, Dacou-Voutetakis C, Karantza M, Kanaka-Gantenbein C, Chrousos GP, Voutetakis A: Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene. J Clin Endocrinol Metab 2014;99:E647-E651.
24.
Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, Jorge BH, Arnhold IJ, Mendonca BB: Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 1999;84:3539-3544.
25.
Neely EK, Hintz RL, Wilson DM, Lee PA, Gautier T, Argente J, Stene M: Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr 1995;127:40-46.
26.
Resende EA, Lara BH, Reis JD, Ferreira BP, Pereira GA, Borges MF: Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children. J Clin Endocrinol Metab 2007;92:1424-1429.
27.
Macedo DB, Abreu AP, Reis AC, Montenegro LR, et al: Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. J Clin Endocrinol Metab 2014;99:E1097-E1103.
28.
Teles MG, Bianco SD, Brito VN, Trarbach EB, Kuohung W, Xu S, Seminara SB, Mendonca BB, Kaiser UB, Latronico AC: A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008;358:709-715.
29.
San Lucas FA, Wang G, Scheet P, Peng B: Integrated annotation and analysis of genetic variants from next-generation sequencing studies with variant tools. Bioinformatics 2012;28:421-422.
30.
National Heart, Lung, and Blood Institute: Exome variant server, NHLBI GO Exome Sequencing Project (ESP). http://evsgswashingtonedu/EVS/2013.
31.
Frousios K, Iliopoulos CS, Schlitt T, Simpson MA: Predicting the functional consequences of non-synonymous DNA sequence variants - evaluation of bioinformatics tools and development of a consensus strategy. Genomics 2013;102:223-228.
32.
Min L, Nie M, Zhang A, Wen J, Noel SD, Lee V, Carroll RS, Kaiser UB: Computational analysis of missense variants of G protein-coupled receptors involved in the neuroendocrine regulation of reproduction. Neuroendocrinology 2016;103:230-239.
33.
Lee HS, Jin HS, Shim YS, Jeong HR, Kwon E, Choi V, Kim MC, Chung IS, Jeong SY, Hwang JS: Low frequency of MKRN3 mutations in central precocious puberty among Korean girls. Horm Metab Res 2015;48:118-122.
34.
Kansakoski J, Raivio T, Juul A, Tommiska J: A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty. Pediatr Res 2015;78:709-711.
35.
Simon D, Ba I, Mekhail N, Ecosse E, Paulsen A, Zenaty D, Houang M, Jesuran Perelroizen M, de Filippo GP, Salerno M, Simonin G, Reynaud R, Carel JC, Leger J, de Roux N: Mutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty. Eur J Endocrinol 2015;174:1-8.
36.
Juul A, Magnusdottir S, Scheike T, Prytz S, Skakkebaek NE: Age at voice break in Danish boys: effects of pre-pubertal body mass index and secular trend. Int J Androl 2007;30:537-542.
37.
Harries ML, Walker JM, Williams DM, Hawkins S, Hughes IA: Changes in the male voice at puberty. Arch Dis Child 1997;77:445-447.
38.
de Brito VN, Latronico AC, Arnhold IJ, Lo LS, Domenice S, Albano MC, Fragoso MC, Mendonca BB: Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Arch Dis Child 1999;80:231-234.
39.
Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jimenez JF, Aiman EJ, DeVane GW, Redman JF, Elders MJ: Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab 1981;52:271-278.
40.
Reiter EO, Brown RS, Longcope C, Beitins IZ: Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit. N Engl J Med 1984;311:515-519.
41.
Bianco SD: A potential mechanism for the sexual dimorphism in the onset of puberty and incidence of idiopathic central precocious puberty in children: sex-specific kisspeptin as an integrator of puberty signals. Front Endocrinol (Lausanne) 2012;3:149.
42.
Latronico AC, Brito VN, Carel JC: Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol 2016;4:265-274.
43.
Hagen CP, Sorensen K, Mieritz MG, Johannsen TH, Almstrup K, Juul A: Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls. J Clin Endocrinol Metab 2015;100:1920-1926.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.